| 102119-5 |
Skeletal muscle channelopathy multigene panel |
- |
Bld/Tiss |
Pt |
- |
Molgen |
|
ACTIVE |
Skeletal muscle channelopathy multigene panel - Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MOLPATH |
|
102119-5 |
|
Molgen |
|
|
Order |
|
|
|
0 |
SMC multigene panel Bld/T |
|
|
|
N |
|
Blood; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; Musc; Muscl; Pan; Panel.molpath; Panl; PCR; Pnl; Point in time; Random; SMC multigene panel; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 95865-2 |
LCDS v4.00 - Swallowing &or nutritional status |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
LCDS v4.00 - Swallowing/nutritional status during assessment period [CMS Assessment] |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
95865-2 |
|
CMS Assessment |
|
|
Subset |
|
|
|
0 |
|
|
|
|
|
|
Centers for Medicare and Medicaid Assessment; Deglutition; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey; Swallowing/nutritional status |
2.77 |
2.69 |
|
Organizer |
|
|
|
|
|
|
|
|
Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; |
0 |
| 95942-9 |
Influenza virus A & Influenza virus B & SARS coronavirus+SARS coronavirus 2 Ag panel |
- |
Respiratory system specimen.upper |
Pt |
- |
IA.rapid |
|
ACTIVE |
Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
95942-9 |
|
IA.rapid |
|
|
Order |
|
|
|
0 |
FLUABV+SARS-CoV Ag Pnl Up resp IA.rapid |
|
|
|
|
|
2019 Novel Coronavirus; 2019-nCoV; Avian influenza; Bird flu; Breathing; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUABV+SARS-CoV Ag Pnl; FLUAV; FLUB; FLUBV; FLUV; Fowl plague; IAA; ID; II; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza B; Influenza B virus; Lungs; MEIA; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV+SARS-CoV-2; SARS-CoV+SARS-CoV-2 Ag; SARS-CoV-1; SARS-CoV-2; Severe Acute Respiratory Syndrome; Spec; SUDS; Up; Upper resp; Viral Pneumonias; Wuhan coronavirus |
2.77 |
2.69 |
|
Panel |
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 96100-3 |
LCDS v5.00 - Mobility - discharge performance |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
LCDS v5.00 - Mobility - discharge performance during assessment period [CMS Assessment] |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
96100-3 |
|
CMS Assessment |
|
|
Subset |
|
|
|
0 |
|
|
|
|
|
|
Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.77 |
2.69 |
|
Organizer |
|
|
|
|
|
|
|
|
|
0 |
| 104563-2 |
PhenX - food swamp protocol 290501 |
- |
^Patient |
Pt |
- |
PhenX |
|
ACTIVE |
PhenX - food swamp protocol 290501 |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
104563-2 |
|
PhenX |
|
|
Order |
|
|
|
0 |
Food stamp protcl |
|
|
|
N |
|
Food stamp protcl; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104825-5 |
Medication strength presentation information |
- |
Medication |
Pt |
- |
|
|
ACTIVE |
Medication strength presentation information Medication |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MEDS |
|
104825-5 |
|
|
|
|
Order |
|
|
|
0 |
Med strength present info Medication |
|
|
|
N |
|
Med; Med strength; Med strength present info; MEDS; Pan; Panel; PANEL.MEDS; Panl; Pnl; Point in time; Random |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104828-9 |
Intercellular substance & basement membrane Ab.IgA panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Intercellular substance and basement membrane Ab.IgA panel - Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEM/BC |
|
104828-9 |
|
|
|
|
Order |
|
|
|
0 |
Intercellular sub & bmt IgA pnl |
|
|
|
N |
|
Basem; Basemt; BM; Cell surface; HEMATOLOGY/CELL COUNTS; ICS; Immune globulin A; Immunoglobulin A; Intercellular structure; Intercellular substance & basement membrane Ab.IgA pnl; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Paraneoplastic pemphigus; Pemphigus; Pnl; Point in time; Random; Serum; SR; Subs |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 98008-6 |
Neonatal infant pain scale panel |
- |
^Patient |
Pt |
- |
NIPS |
|
DEPRECATED |
Deprecated Neonatal infant pain scale panel |
|
DEL |
DefinitionDescription |
|
|
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
PANEL.NEONAT |
|
98008-6 |
|
NIPS |
|
|
Order |
|
|
|
0 |
Deprecated NIPS |
|
|
|
N |
|
Pan; PANEL.NEONAT; Panl; Pnl; Point in time; Random |
2.75 |
2.7 |
|
Panel |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 86822-4 |
MDS v3.0 - RAI v1.17.2 - Health conditions - ND, SD |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
MDS v3.0 - RAI v1.17.2 - Health conditions - ND, SD during assessment period [CMS Assessment] |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
86822-4 |
|
CMS Assessment |
|
|
Subset |
|
|
|
0 |
|
|
|
|
|
|
Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.77 |
2.63 |
|
Organizer |
|
|
|
|
|
|
|
|
Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; Release 2.68: COMPONENT: Assessment version number was updated to reflect the most recent version.; Previous Releases: This panel is in version 1.14.1, 1.15.1, and 1.16.1. So "v1.16.1" was added to the Component; Current convention (as approved by the joint CMS LTPAC & LOINC project team) will list only the most current assessment in the Component for CMS Assessment panels. |
0 |
| 103564-1 |
MDS v3.0 - RAI v1.19.1 - Nursing home comprehensive (NC) item set |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
MDS v3.0 - RAI v1.19.1 - Nursing home comprehensive (NC) item set during assessment period [CMS Assessment] |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
103564-1 |
|
CMS Assessment |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; MDS v3.0 - RAI v1.19.1 - NC; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.79 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104595-4 |
Dengue virus Ab.IgG & IgM & NS1 Ag panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Dengue virus Ab.IgG and IgM and NS1 Ag panel - Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
104595-4 |
|
|
|
|
Order |
|
|
|
0 |
Dengue virus Ab.IgG+IgM+NS1 Ag pnl SerPl |
|
|
|
N |
|
Breakbone fever; Dengue virus Ab.IgG + IgM + NS1 Ag panel; DENV; Flavivirus; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104596-2 |
Phenytoin & Phenobarbital panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Phenytoin and Phenobarbital panel - Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
104596-2 |
|
|
|
|
Order |
|
|
|
0 |
Phenytoin & Phenobarbital pnl Ser |
|
|
|
N |
|
Barbiturate; c417; DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; DRUG/TOXICOLOGY; Drugs; Epanutin; Fenantoin; Lehydan; Luminal; Nirvonal; Pan; PANEL.DRUG & TOXICOLOGY; Panl; PHBR; Phenhydan; Phenobarb; Phenytoin & Phenobarbital pnl; PHYT; Pnl; Point in time; Random; Serum; Sinergina; SR; Zentropil |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104599-6 |
Fungal susceptibility panel |
- |
Isolate |
Pt |
OrdQn |
MIC |
|
ACTIVE |
Fungal susceptibility panel - Isolate by Minimum inhibitory concentration (MIC) |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
104599-6 |
|
MIC |
|
|
Order |
|
|
|
0 |
Fungal Susc Pnl Islt MIC |
|
|
|
N |
|
Fungal Susc Pnl; Islt; Isol; Microbiology; MINIMUM INHIBITORY CONCENTRATION; Mould Susceptibility Panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Sus; Susc; Suscept; Susceptibilities; Susceptibilty |
2.79 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
Release 2.79: CLASS: Panel class for panel code; |
0 |
| 104991-5 |
Bacterial resistance panel |
- |
Isolate |
Pt |
- |
|
|
ACTIVE |
Bacterial resistance panel |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.ABXBACT |
|
104991-5 |
|
|
|
|
Order |
|
|
|
0 |
Bacterial resist pnl Islt |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial resist pnl; Islt; Isol; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104992-3 |
Paraneoplastic vision loss evaluation panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Paraneoplastic vision loss evaluation panel - Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SERO |
|
104992-3 |
|
|
|
|
Order |
|
|
|
0 |
Para vis loss eval pnl Ser |
|
|
|
N |
|
Assessment; Eval; H&P; History and physical; Pan; PANEL.SEROLOGY; Panl; Para vis loss eval pnl; Paran vis loss; Pnl; Point in time; Random; Serology; Serum; SR |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104606-9 |
MDS v3.0 - RAI v1.19.1 - Nursing home discharge (ND) item set |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
MDS v3.0 - RAI v1.19.1 - Nursing home discharge (ND) item set during assessment period [CMS Assessment] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
104606-9 |
|
CMS Assessment |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; Disch; MDS v3.0 - RAI v1.19.1 - ND; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104607-7 |
MDS v3.0 - RAI v1.19.1 - Swing Bed discharge (SD) item set |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
MDS v3.0 - RAI v1.19.1 - Swing Bed discharge (SD) item set during assessment period [CMS Assessment] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
104607-7 |
|
CMS Assessment |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; Disch; MDS v3.0 - RAI v1.19.1 - SD; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104608-5 |
MDS v3.0 - RAI v1.19.1 - Interim Payment Assessment (IPA) item set |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
MDS v3.0 - RAI v1.19.1 - Interim Payment Assessment (IPA) item set during assessment period [CMS Assessment] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
104608-5 |
|
CMS Assessment |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; MDS v3.0 - RAI v1.19.1 - IPA; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 105008-7 |
MDS v3.0 - RAI v1.19.1 - Nursing home and Swing bed tracking (NT ST) item set |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
MDS v3.0 - RAI v1.19.1 - Nursing home and Swing bed tracking (NT ST) item set during assessment period [CMS Assessment] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
105008-7 |
|
CMS Assessment |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; MDS v3.0 - RAI v1.19.1 - NT & ST; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104873-5 |
Glucose dumping syndrome panel |
- |
Ser/Plas/Bld |
Pt |
- |
|
|
ACTIVE |
Glucose dumping syndrome panel - Serum, Plasma or Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEM/BC |
|
104873-5 |
|
|
|
|
Order |
|
|
|
0 |
GDS pnl SerPlBld |
|
|
|
N |
|
Blood; GDS pnl; Glu; Gluc; Glucoseur; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pl; PlasBld; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104609-3 |
MDS v3.0 - RAI v1.19.1 - Swing bed PPS (SP) item set |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
MDS v3.0 - RAI v1.19.1 - Swing bed PPS (SP) item set during assessment period [CMS Assessment] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
104609-3 |
|
CMS Assessment |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; MDS v3.0 - RAI v1.19.1 - SP; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; species; spp; Survey |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104884-2 |
Tubular reabsorption of phosphorus panel |
- |
Urine+Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Tubular reabsorption of phosphorus panel - Urine and Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
104884-2 |
|
|
|
|
Order |
|
|
|
0 |
Tubular reabsorp phos pnl Ur+SerPl |
|
|
|
N |
|
Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TmP; Tubular reabsorp phos pnl; UA; UR; Ur+SerPl; Urn |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104626-7 |
Methadone Confirmatory panel |
- |
Urine |
Pt |
- |
|
|
ACTIVE |
Methadone Confirmatory panel - Urine |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
104626-7 |
|
|
|
|
Order |
|
|
|
0 |
Methadone Confirmatory pnl Ur |
|
|
|
N |
|
Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; METD; Methadone Confirmatory pnl; Methadose; MTD; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104632-5 |
Metanephrine & Normetanephrine & Total metanephrines panel |
- |
Urine |
24H |
- |
|
|
ACTIVE |
Metanephrine, Normetanephrine and Total metanephrines panel - 24 hour Urine |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
104632-5 |
|
|
|
|
Order |
|
|
|
0 |
Met+normet+ tot met pnl 24h Ur |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Met+normet+ tot met pnl; Metaneph; Metaneph+Normetaneph; Metanephrine fractionated; Metanephrine+normetanephrine; Metanephrne; MetanephS; Metenephrine; Normeta; Normetaneph; Normetanephrn; Pan; PANEL.CHEMISTRY; Panl; Pnl; Tot; Totl; UA; UR; Urn |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 104922-0 |
Laboratory test details panel |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Laboratory test details panel |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.ADMIN |
|
104922-0 |
|
|
|
|
Order |
|
|
|
0 |
Laboratory test details panel |
|
|
|
N |
|
ADMIN; Pan; PANEL.ADMIN; Panl; Pnl; Point in time; Random |
2.79 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
Release 2.79: ORDER_OBS: Panel code; |
0 |
